Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses

Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses

COVID-19 and influenza both cause enormous disease burdens, and vaccines are the primary measures for their control. Since these viral diseases are transmitted through the mucosal surface of the respiratory tract, developing an effective and convenient mucosal vaccine should be a high priority. We p...

Full description

Bibliographic Details
Main Authors: Maggie Jing Ouyang, Zhujun Ao, Titus A. Olukitibi, Peter Lawrynuik, Christopher Shieh, Sam K. P. Kung, Keith R. Fowke, Darwyn Kobasa, Xiaojian Yao
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Vaccines
Subjects:
COVID-19
oral immunization
bivalent vaccine
vesicular stomatitis virus (VSV)
VSV vector
SARS-CoV-2
Online Access:https://www.mdpi.com/2076-393X/11/9/1404

Internet

https://www.mdpi.com/2076-393X/11/9/1404

Similar Items